Cargando…
Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome
Autores principales: | Lee, Hyun Jung, Kim, Won-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186657/ https://www.ncbi.nlm.nih.gov/pubmed/32355711 http://dx.doi.org/10.21037/atm.2020.02.82 |
Ejemplares similares
-
Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
por: O’Kane, Cecilia M., et al.
Publicado: (2022) -
Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19–related Acute Respiratory Distress Syndrome
por: Zhang, Haibo, et al.
Publicado: (2023) -
Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome
Supported with Extracorporeal Membrane Oxygenation. Lost in Translational
Research?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2020) -
Physiology Is Vital to Precision Medicine in Acute Respiratory Distress Syndrome and Sepsis
por: Goligher, Ewan C., et al.
Publicado: (2022) -
Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019
por: Whittaker Brown, Stacey-Ann, et al.
Publicado: (2022)